Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

@article{Lieberman2005EffectivenessOA,
  title={Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.},
  author={J. Lieberman and T. Stroup and J. McEvoy and M. Swartz and R. Rosenheck and D. Perkins and R. Keefe and S. Davis and C. E. Davis and B. Lebowitz and J. Severe and J. Hsiao},
  journal={The New England journal of medicine},
  year={2005},
  volume={353 12},
  pages={
          1209-23
        }
}
BACKGROUND The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. [...] Key MethodRESULTS Overall, 74 percent of patients discontinued the study medication before 18 months (1061 of the 1432 patients who received at least one dose): 64 percent of those assigned to olanzapine, 75 percent of those assigned to perphenazine, 82 percent of those assigned to…Expand

Paper Mentions

Interventional Clinical Trial
Study Purpose: This study will explore the feasibility of administering Holographic Memory Resolution® (HMR) to adults who are experiencing chronic pain for 6 months or more.  
ConditionsChronic Pain, Headache, Migraine, Stress Disorders, Post-Traumatic
InterventionBehavioral
Interventional Clinical Trial
While the scientific understanding of pharmacogenomics is quickly accelerating, its translation to clinical decision-making (especially in psychiatric practice) has progressed… Expand
ConditionsPain, Psychiatric Disorders
InterventionDrug
Interventional Clinical Trial
This application seeks renewed support for MH59803, "Dopaminergic substrates of startle gating across species," to extend a clear path of "bench-to-bedside" progress towards a… Expand
ConditionsSchizophrenia
InterventionDrug
Effectiveness of second-generation antipsychotics with acute-phase schizophrenia
TLDR
Olanzapine and risperidone are superior to quetiapines and aripiprazole for the acute treatment of psychosis in hospitalized patients. Expand
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
TLDR
This pragmatic trial suggests that clinically meaningful antipsychotic treatment of first-episode of schizophrenia is achievable, for at least 1 year, but it cannot conclude that second-generation drugs are more efficacious than is haloperidol, since discontinuation rates are not necessarily consistent with symptomatic improvement. Expand
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
TLDR
Among this group of patients with chronic schizophrenia who had just discontinued the older antipsychotic perphenazine, quetiapine and olanzapine were more effective than risperidone, as reflected by longer time to discontinuation for any reason. Expand
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
TLDR
Among this group of patients with chronic schizophrenia who had just discontinued treatment with an atypical antipsychotic, risperidone and olanzapine were more effective than quetiapine and ziprasidone as reflected by longer time until discontinuation for any reason. Expand
Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
TLDR
Aripiprazole may be considered the best available option for long-term treatment of patients with schizophrenia or schizoaffective disorder because of the time to discontinuation of each second-generation antipsychotic. Expand
Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
TLDR
The results indicate that both atypical antipsychotic medications provided significant additional improvement in symptom severity in patients with schizophrenia previously on conventional antipsychotics. Expand
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
TLDR
It is concluded that there is a very high rate of discontinuation of the initial antipsychotic medications for various reasons, with risperidone having an overall longer time to discontinuation compared with first-generation antipsychotics medications. Expand
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
TLDR
If there were differences between these four treatments in effectiveness measured by time until discontinuation for any reason, this randomized, double-blind study compared them in patients who had just discontinued a different atypical antipsychotic. Expand
Ann schizophrenia-spectrum disorders Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with
This naturalistic retrospective study aims to compare effectiveness of a second-generation antipsychotic medication, risperidone, with first-generation antipsychotic medications (haloperidol andExpand
Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study
TLDR
The efficacy of seven antipsychotic medications for the maintenance treatment appeared similar in early-stage schizophrenia, and special programs are needed to keep efficacy and safety of antipsychotics maintenance treatment for schizophrenia with early stage schizophrenia. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
TLDR
Olanzapine does not demonstrate advantages compared with haloperidol (in combination with prophylactic benztropine) in compliance, symptoms, extrapyramidal symptoms, or overall quality of life, and its benefits in reducing akathisia and improving cognition must be balanced with the problems of weight gain and higher cost. Expand
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
TLDR
A brief review and critique of the current therapeutic armamentarium for treating schizophrenia and drug development strategies and theories of mechanisms of action of antipsychotic drugs is provided, and focuses on novel targets for therapeutic agents for future drug development. Expand
Dose Response and Dose Equivalence of Antipsychotics
TLDR
Evidence from randomized, placebo-controlled studies of patients with schizophrenia or schizoaffective disorder, which compared 2 or more doses of an antipsychotic to calculate the dose-response curve is reviewed to find 3.3 to 10 mg haloperidol to be the near-maximal ED range. Expand
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
TLDR
New generation drugs were moderately more efficacious than low-potency antipsychotics, largely irrespective of the comparator doses used, and potential advantages in efficacy of the new generation drugs should be a factor in clinical treatment decisions to use these rather than conventional drugs. Expand
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
TLDR
Adult outpatients with clinically stable schizophrenia or schizoaffective disorder have a lower risk of relapse if they are treated with risperidone than if they were treated with haloperidol. Expand
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
TLDR
The equal effectiveness and tolerability of new atypical drugs in comparison with clozapine is not yet demonstrated, and more trials of sufficient power, with longer duration, and measuring clinically important outcomes are urgently needed. Expand
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
TLDR
In this relatively brief study, the apparently increased comparative risk of agranulocytosis requires that the use of clozapine be limited to selected treatment-resistant patients. Expand
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
TLDR
Some SGAs are more efficacious than FGAs, and, therefore,SGAs are not a homogeneous group, as suggested by consensus panel recommendations. Expand
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
TLDR
It is confirmed that treatment-resistant schizophrenic patients have more favorable outcomes when treated with clozapine rather than a typical antipsychotic, as reflected by Brief Psychiatric Rating Scale total score, categorical response rate, Scale for the Assessment of Negative Symptoms score, Simpson-Angus Rating Scale score, and compliance rate. Expand
An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.
TLDR
A strong association between olanZapine exposure and hyperlipidemia in schizophrenic patients is observed and the possible metabolic consequences of olanzapine use should be given serious consideration by treating physicians. Expand
...
1
2
3
4
...